TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 158 (8), 2266-2281.e27
- https://doi.org/10.1053/j.gastro.2020.02.033
Abstract
No abstract availableFunding Information
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
This publication has 51 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and SignalingCell Metabolism, 2012
- Berardinelli-Seip Congenital Lipodystrophy 2/Seipin Is a Cell-Autonomous Regulator of Lipolysis Essential for Adipocyte DifferentiationMolecular and Cellular Biology, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescentsJournal of Hepatology, 2010
- Brown Fat and the Myth of Diet-Induced ThermogenesisCell Metabolism, 2010
- Distinct Dysregulation of Lipid Metabolism by Unliganded Thyroid Hormone Receptor IsoformsMolecular Endocrinology, 2009
- Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient MiceMolecular and Cellular Biology, 2007
- Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitisJournal of Hepatology, 2003